Dose reduction of edoxaban preserves efficacy and safety for the treatment of venous thromboembolism. An analysis of the randomised, double-blind HOKUSAI VTE trial - Verhamme, P; Wells, P S; Segers, A (Thromb Haemost, 2016)
, et al.